Ixekizumab (Anti-CTLA-8 / IL-17a)

製品コード：A2862         Batch: A286202

印刷

Ixekizumab (Anti-CTLA-8 / IL-17a) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab has the potential to be used in research on plaque psoriasis. MW: 146.44 KD.

製品説明

CAS No. 1143503-69-8
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Isotype Human IgG4SP
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 7.307mg/ml
Endotoxin Level ＜1EU/mg

人間や獣医の診断であるか治療的な使用のためにでない。